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Abstract		
Question: How ‘healthy’ do children need to be when selecting reference samples 
for spirometry?  
Methods: Anthropometry and spirometry were measured at school in an unselected, 
multi-ethnic population of London children aged 5-11yrs, with follow-up assessments 
1yr later. Parents provided information on children’s birth data and health status. 
FEV1 and FVC were adjusted for sex, age, height and ethnicity using the GLI-2012 
equations, and the effects of potential exclusion criteria on the z-score distributions 
were examined. 
Results: After exclusions for current and chronic lung disease, acceptable data were 
available for 1901 children on 2767 occasions. “Healthy” children were defined as 
those without prior asthma or hospitalisation for respiratory problems, born full-term 
with birthweight ≥2.5kg and asymptomatic at test. Mean(SD) z-scores for FEV1 and 
FVC approximated 0(1) indicating the GLI-2012 equations were appropriate for this 
“healthy” population. However, if children born preterm, or with low birthweight, prior 
asthma or mildly symptomatic at test were included in the reference, results overall 
were similar to those for “healthy” children, while increasing the sample size by 25%. 
Answer: With the exception of clear-cut factors such as current and chronic 
respiratory disease, paediatric reference samples for spirometry can be relatively 
inclusive and hence more generalisable to the target population.  
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Introduction	
The inclusion and exclusion criteria applied to subjects in population-based studies 
of lung function vary according to the underlying question and study design [1]. 
Excluding subjects with prior potentially adverse exposures may be appropriate 
when establishing normative data for reference equations [2,3], but less so in studies 
exploring the early determinants of lung function during childhood [4]. Furthermore, 
when collecting data in schools, it may be more efficient to include all children and 
subsequently exclude some, rather than exclude children on ‘health’ grounds at the 
outset, which may cause embarrassment and upset. Similarly, although paediatric 
research studies often exclude lung function measurements within 3 [5] or 6 weeks 
[2] of upper respiratory infections, children frequently suffer from such symptoms and 
their impact of such symptoms on the results is unclear. Reassessing the child when 
they are symptom-free is less easy for school-based studies than for laboratory 
studies [5].  
The aim of this study was to examine the extent to which exclusions due to current 
upper respiratory symptoms or a history of potential adverse events such as low 
birthweight (LBW), preterm birth or prior wheezing/asthma impact on the distribution 
of spirometric z-scores in the context of a large population-based study.  
  	
5 
 
Methods	
The Size and Lung function In Children (SLIC) study was designed to explore ethnic 
differences in lung function and body physique in a multi-ethnic population of London 
school children aged 5-11 years recruited from 14 London primary schools (2010-
2013) (www.ucl.ac.uk/slic) [6]. Schools were sampled by education performance 
within boroughs to ensure a wide range of socio-economic circumstances. 
Anthropometry and spirometry (Easy-on-PC, ndd, Switzerland) were performed in 
school according to international standards adapted for children [7,8]with follow-up 
assessments 12 months later. All assessments were undertaken by the same team 
of paediatric respiratory physiologists, using identical equipment and standardised 
protocols, with subsequent over-read by a senior respiratory physiologist to ensure 
appropriate quality control. Spirometry results were expressed as z-scores using the 
ethnic-specific GLI-2012 equations, which adjust for, sex, age, height and ethnicity, 
for forced expired volume in 1 second (FEV1), forced vital capacity (FVC) and 
FEV1/FVC [9]. Parents completed questionnaires about their child’s ethnicity, birth 
data, and current and prior health status. Ethnicity was coded as White, Black 
(Black-African or Black-Caribbean), South-Asian (Indian sub-continent), or 
Other/mixed. The study was approved by the London-Hampstead research ethics 
committee. Parents’ written consent and children’s verbal assent were obtained prior 
to assessments. Some results from this study have been reported previously [10,11]. 
This study explores the impact of different exclusion criteria on mean spirometry 
results. Five exclusion criteria were considered: 
1. current or chronic lung disease (e.g. sickle cell disease; cystic fibrosis; current 
asthma [either doctor-diagnosed or asthma medication in the past 12 months, 
with or without current symptoms/wheeze]) 
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2. congenital abnormality likely to impact on lung development 
3. born preterm (gestational age < 37 weeks) or birthweight < 2.5 kg  
4. prior doctor-diagnosed asthma or hospitalisation for respiratory problems 
5. symptomatic (cough or cold) at test.  
The first two exclusions were considered mandatory, while the impact of applying the 
remaining three was tested by comparing the overall results with and without them. 
Statistical analysis 
Results are presented as frequencies (%) for categorical variables and as mean 
(SD) or median (range) for continuous outcomes. Student’s t test was used to 
compare mean differences in lung function between groups. The impact on the 
distribution of spirometry z-scores with different exclusion criteria was examined by 
comparing the mean and SD of the z-scores.  
 
Results	
Assessments were attempted in 2171 children on 3302 test occasions (including 
those from an initial feasibility study in two schools [6]). Of these, 125 children were 
excluded on technical grounds (124 who failed spirometry on all 279 test occasions, 
and one with missing height). A further 145 children (255 test occasions) were 
excluded under exclusion criteria 1 or 2: current or chronic lung disease, or 
congenital abnormality (Table 1). Technically satisfactory spirometry was obtained 
for the remaining 1901 children on 2767 test occasions (46% boys; 35% White, 29% 
Black, 24% South-Asian, 12% other/mixed ethnicity; mean (range) age 8.3 (5.2-11.9) 
years). Technically  acceptable spirometric data could not be obtained on 7.5% of all 
test occasions in “healthy” children, this failure rate being significantly higher among 
children with congenital abnormalities [% mean difference (95% CI): 18% (6.6%; 
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35%)],  current asthma [5.2% (2.5%; 8.5%)], or those who were symptomatic at time 
of test  [26% (21%; 31%)].  
 
Table 1: Group characteristics and lung function of 145 children excluded from analysis by 
criteria 1 and 2. 
  
Congenital  
abnormality* 
Sickle cell 
disease 
Current  
asthma 
Total 
Subjects (n) 9 12 124 145 
Boys (%) 78% 17% 56% 54% 
White (%) 56% 17% 32% 32% 
Test occasions# (n) 8 18 192 218 
Age at test (y) 8.6 (1.88) 8.4 (1.83) 8.7 (1.55) 8.7 (1.58) 
zHeight§  -0.17 (1.87) 0.51 (1.03) 0.27 (1.29) 0.28 (1.3) 
zFEV1 0.19 (2.68)  -0.50 (1.01)  -0.27 (1.04) -0.27 (1.13) 
zFVC 0.27 (2.82)  -0.37 (1.00) 0.22 (0.99) 0.17 (1.10) 
zFEV1/FVC  -0.05 (0.90)  -0.29 (1.04)  -0.85 (0.96) -0.77 (0.98) 
Data presented are Mean (SD) unless otherwise specified. §according to the British 1990 
reference[12]. *6 children with congenital or neurological abnormalities and 3 with growth 
abnormalities. #Test occasions with technically acceptable spirometry results. 
 
Table 2 shows the 1901 children without chronic disease split into groups by 
identifying those meeting each of the exclusion criteria 3 to 5, while the remaining 
1520 children constitute the “healthy” group. Among the children born preterm and/or 
low birthweight, the median [range] gestational age was 36 [23-41] weeks, with only 
5 (2.7%) being born before 28 weeks gestation representing 0.3% of the reference 
population. Similarly the mean [range] birthweight for this subgroup was 2.27 [0.73-
4.0] kg, with only 3 (1.6%) children having a birthweight <1kg. There was some 
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overlap across the three exclusion groups, with between 6% and 13% of children per 
group meeting more than one exclusion criterion. The proportions of children 
meeting the various criteria were similar across ethnic groups [6].  
The mean (SD) of the FEV1 and FVC z-scores (zFEV1 and zFVC respectively) 
approximated 0 (1) in the “healthy” group, indicating that the GLI-2012 reference 
equations were broadly appropriate for this multi-ethnic population (Table 2). 
Although there were no significant differences in zFVC between the four groups, 
zFEV1 and zFEV1/FVC were significantly lower in those with “prior asthma” or 
“symptomatic at test” by up to 0.3 z-scores for FEV1 (equating to ~ 3.5% if expressed 
as % predicted) and 0.5 z-scores for FEV1/FVC (Table 2). Similar results were 
observed for FEF25-75 but since FEF25-75 was no more discriminative in detecting 
children with lung function abnormalities than FEV1/FVC (data not shown) [13,14], 
this outcome was not reported for subsequent analyses. 
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Table 2: Group characteristics and lung function according to health statusҰ in 1901 children 
on 2767 test occasions. 
  Healthy Exclusion 
criterion 3: 
Preterm/LBW
Exclusion 
criterion 4: 
Prior asthma 
Exclusion      
criterion 5: 
Symptomatic at test 
Subjects (n) 1520 186 158 111 
Boys (%) 45 46 57 47 
White (%) 37 24 33 38 
Test occasions# (n) 2199 232 208 141 
Age at test (y) 8.5 (1.7) 8.7 (1.6) 8.4 (1.7) 8.4 (1.5) 
zHeight§ 0.48 (1.05) 0.23 (1.16) 0.41 (1.14) 0.45 (1.01) 
zFEV1 0.03 (0.90) -0.11 (1.00) -0.27 (0.96)*** -0.29(1.12)*** 
zFVC 0.17 (0.92) 0.11 (0.97) 0.12 (0.87) 0.02 (1.10) 
zFEV1/zFVC -0.27 (0.95) -0.41 (1.00) -0.72 (1.02)*** -0.55 (1.11)*** 
Data presented are mean (SD) unless otherwise specified. Ұexclusion criteria not mutually exclusive; 
§according to the British 1990 reference[12]. LBW: Low birthweight (<2.5kg); *** p <0.001 compared 
to lung function from “Healthy” children. #Test occasions with technically acceptable spirometry 
results. 
 
Impact of health status on lung function 
Relaxing the exclusion criteria to progressively include a) children born preterm 
and/or LBW, b) those with prior asthma and c) those symptomatic at test, had only 
minor effects on the z-score distributions of FEV1, FVC and FEV1/FVC for the entire 
group (Table 3). Thus, despite the significant differences between the groups seen in 
Table 2, the fact that the exclusion groups were relatively small meant that including 
them with the “healthy” group made little difference to the combined z-score 
distributions, but increased the reference sample size by 381 children or 25%.  
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Furthermore, the decrement of lung function among those with current asthma or 
chronic lung disease could still be distinguished from the “reference sample” (e.g. 
mean difference (95%CI) [Reference Population-Current Asthma] zFEV1: 0.26 (0.10; 
0.41); zFEV1/FVC: 0.53 (0.39; 0.67)). 
 
Table 3: Impact of health status on lung function. 
 Healthy 
+ Preterm/ 
LBW 
+ Prior  
asthma 
+ Symptomatic  
at test 
Subjects (n) 1520 1676 1825 1901 
Boys (%) 45% 45% 46% 46% 
Test occasions# (n) 2199 2431 2626 2767 
zFEV1 0.03 (0.90) 0.02 (0.90) 0.00 (0.91) -0.01 (0.92) 
zFVC 0.17 (0.92) 0.17 (0.92) 0.17 (0.92) 0.16 (0.93) 
zFEV1/FVC -0.27 (0.95) -0.28 (0.95) -0.31 (0.96) -0.32 (0.97) 
Footnote: Data presented are mean (SD) unless otherwise indicated. LBW: Low birthweight (<2.5 
kg). #Test occasions with technically acceptable spirometry results. 
 
The 568 tests on the 381 “unhealthy” children constituted 20% of the total reference 
population. To explore how sensitive the conclusions were to this specific proportion, 
corresponding results were calculated by doubling the size of the “unhealthy” group, 
i.e. assuming a 60:40 split between the “healthy” and “unhealthy” test results, rather 
than the observed 80:20. In practice this had only a small effect on the distribution, 
reducing the means for zFEV1 and zFEV1/FVC by 0.04 and 0.05 respectively (no 
change noticed for mean zFVC), while increasing the SDs by 0.01 (changes which  
happen to match the actual differences between the healthy and combined groups 
(columns 1 and 4 in Table 3). Thus the conclusions do not depend critically on the 
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proportion of “unhealthy” children recruited from a large population sample, provided 
the sample is unselected and that there is no gross reduction in lung function among 
such children. 
 
Discussion		
Our study shows that, with the exception of children with clearly defined current or 
chronic disease, reference samples for paediatric spirometry can be relatively all-
inclusive and thus more representative of the general population. While factors such 
as low birthweight, preterm delivery, prior asthma and symptoms at test introduce 
bias in individuals, they do not have a substantial impact in large epidemiological 
studies due to the relatively small proportion of affected children, and the relatively 
mild reductions in lung function observed when recruiting an unselected population. 
Using this approach, the expanded sample in our study was not only more 
representative of the underlying population but also 25% larger, thereby increasing 
cost effectiveness. 
 
A major strength of our study is that all the assessments were undertaken by the 
same team using identical equipment and standardised protocols, with subsequent 
over-read by an experienced physiologist to ensure a high degree of quality control 
and reliability.  As recently reported by others [13,14]. we found very little 
discordance between FEF25-75 and FEV1/FVC when classifying test results, 
suggesting forced expiratory flows do not contribute to clinical decision making in 
either children or adults. We recommend limiting the reporting of spirometry 
outcomes to FEV1, FVC and FEV1/FVC as recommended by the ATS/ERS 
guidelines [15].  
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The study was designed to assess children in school without parents needing to be 
present. This maximised recruitment and reduced bias that may have occurred had 
parents had to take time off work, wherein those with potential anxieties about their 
child’s lung health may have been more willing to enrol. The proportions of preterm 
children and those with a diagnosis of asthma in the study were small, and similar to 
those reported for England and Wales (6% for GA<37; 0.4% for GA <28w and 9% for 
asthma) [16,17]. The study sample was also representative of an inner city 
population of multi-ethnic school children [18]. For the purposes of this study, any 
child born < 2.5 kg or < 37 weeks gestation was classified as low birthweight or 
preterm respectively, but the vast majority of such children were relatively mature  
(71% of this group being ≥ 35 weeks GA and 67% ≥ 2kg birthweight), when any 
deficiencies in lung function are likely to be relatively minor [19].  
 
The fact that neither prematurity nor low birthweight adversely affected the results in 
this ‘unselected’ study where such children represent only 8% of the population, 
does not diminish their potential impact in individual children, especially those who 
are born extremely preterm or of very low birth weight, as clearly indicated by 
focussed studies (e.g. with a 50:50 mix), where mean reductions in FEV1 by up to 1 
z-score ( i.e. over 10%) have been reported [4,20,21]. Similarly, the need to record 
relevant prior medical history including birth status, and using such information when 
interpreting results, remains of paramount importance during both research studies 
and the clinical management of individual patients with respiratory disease at any 
age [22]. 
It was reassuring that current upper respiratory symptoms did not influence the 
sample distribution of spirometry, since not all epidemiological studies record 
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symptoms during lung function testing [23] and such symptoms can be very 
subjective. It must however be emphasised that these findings apply only to 
spirometry, which is expected to be relatively independent of upper respiratory 
symptoms. Furthermore, the failure rate was almost five times higher in those with 
than without symptoms, suggesting a degree of ‘self-exclusion’, with technically 
acceptable data being achievable only in children with relatively mild symptoms.  
To assess the potential impact of including a higher proportion of “unhealthy” 
children on population estimates of spirometry, we modelled the effect of doubling 
the size of this group. Given that the proportions of children with prior asthma or 
those born preterm/LBW are unlikely to be higher than the unselected population 
sample from which they were recruited (15% of total), the effect of doubling the 
sample size of ‘unhealthy’ children was just a crude approach to show that it makes 
little difference to the results, providing the mean deficit within such groups is 
minimal. The mean values fell slightly and the SDs rose minimally, but in practice the 
impact was minimal, due both to the fact that the proportion of healthy children 
remained in the majority and that there were relatively small group differences in 
lung function between the healthy children and those with symptoms who were well 
enough to attend school and produce technically satisfactory results. It should be 
noted that since a 1 z-score change for FEV1 in 8 year old children is equivalent to 
~12% of predicted FEV1, a difference of 0.04 z-scores when doubling the proportion 
of “unhealthy” children only represents a change of 0.5% in predicted FEV1.  
 
Our results suggest that where a genuinely “healthy” population sample of children is 
required to address a research hypothesis with spirometry as the primary outcome, 
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i.e. where all five exclusion criteria apply, the target sample size needs to be 
increased by at least 30% to cover exclusions.  
 
In conclusion, we found that the mean and SD of spirometry in our study was not 
materially affected by exclusion criteria such as mild current symptoms, prior wheeze 
or LBW. While inclusion/exclusion criteria will always need to be considered carefully 
according to the specific hypotheses under examination, these findings have 
potential  implications for epidemiological studies with respect to the cost, efficiency 
and generalisability of population studies with spirometric lung function as a primary 
outcome.  
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